News By Tag
News By Location
Follow on Google News
High Burden of Chronic Ailments To Drive Label-Free Detection Technology Demand
Moreover, the booming healthcare expenditure and the rising strategic developments for drug discovery will drive the label-free detection technology market at a CAGR of 9.0% during the forecast period (2020–2030).
By: P&S Intelligence
Moreover, the booming healthcare expenditure and the rising strategic developments for drug discovery will drive the label-free detection technology market at a CAGR of 9.0% (https://www.psmarketresearch.com/
Globally, the North American region was the dominant user of label-free detection technology in the last few years, and it will retain its dominance in the foreseeable future as well. This can be owed to the growing prevalence of chronic ailments and soaring healthcare expenditure in Canada and the U.S. For example, Canadian Cancer Statistics reveals that 45% of Canadian men and 43% of Canadian women are suffering from cancer during their lifetime. Further, the Centers for Disease Control and Prevention (CDC) states that 6 in 10 adults in the U.S. suffer from a chronic disease.
Therefore, the rising prevalence of chronic illnesses and the mounting healthcare expenditure will result in the largescale adoption of label-free detection technology, globally.